SCHEMBL19082189

SCHEMBL19082189

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cc5sc6cc7ccccc7cc6c5c5sc6ccccc6c45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.37
WEE1 P30291 1/20 0.37
PTPN1 P18031 3/20 0.34
F9 P00740 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
PTPRC P08575 1/20 0.31
PTPRF P10586 1/20 0.31
PTPRA P18433 1/20 0.31
PTPRB P23467 1/20 0.31
PTPN6 P29350 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN12 Q05209 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944191 0.91 F9 (0.40) CHEK1WEE1PTPN1F9ALDH1A1
SCHEMBL19082204 0.87 LIMK1 (0.33) CHEK1WEE1PTPN1F9ALDH1A1
SCHEMBL19082329 0.85 ESR1 (0.35) CHEK1WEE1PTPN1TNKSTNKS2
SCHEMBL17945663 0.83 PTPN1 (0.41) CHEK1WEE1PTPN1F9ALDH1A1
SCHEMBL19082096 0.83 ESR1 (0.38) CHEK1WEE1PTPN1ALDH1A1HPGD
SCHEMBL17945724 0.82 PTPN1 (0.39) CHEK1WEE1PTPN1F9ALDH1A1
SCHEMBL19082186 0.82 TNKS (0.38) CHEK1WEE1PTPN1F9ALDH1A1
SCHEMBL19081868 0.81 PTPN1 (0.33) WEE1PTPN1F9ALDH1A1HPGD
SCHEMBL19082331 0.81 PTPN1 (0.36) CHEK1WEE1PTPN1ALDH1A1HPGD
SCHEMBL17945695 0.81 PTPN1 (0.39) CHEK1WEE1PTPN1F9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CHEK1 255/4885WEE1 683/4885PTPN1 4695/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CHEK1 255/4885WEE1 683/4885PTPN1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.